Novavax filed for authorization with Health Canada today for its protein-based COVID-19 vaccine. Stanley Erck, President & CEO, Novavax tells BNN Bloomberg that its vaccine can be mixed & matched with others and that it's scaling production globally.
Saturday, January 22, 2022
Novavax files for COVID-19 vaccine authorization with Health Canada
Novavax files for COVID-19 vaccine authorization with Health Canada:
Thursday, January 20, 2022
Sunday, January 2, 2022
Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO
Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO:
The Canadian government and Novavax have signed a deal for the company to produce its COVID-19 vaccine at a facility on Montreal, which could produce up to two million vaccines per month. Novavax CEO, Stanley Erck, joins BNN Bloomberg to discuss.
Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO
Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO:
The Canadian government and Novavax have signed a deal for the company to produce its COVID-19 vaccine at a facility on Montreal, which could produce up to two million vaccines per month. Novavax CEO, Stanley Erck, joins BNN Bloomberg to discuss.
Subscribe to:
Posts (Atom)